CTX310

Trademark usage description

cells for medical or clinical use in the field of in vivo gene editing therapy for the treatment of cardiovascular diseases; pharmaceutical and biopha Read More

Classification Information

Class [005]
Cells for medical or clinical use in the field of in vivo gene editing therapy for the treatment of cardiovascular diseases; pharmaceutical and biopharmaceutical agents for the treatment of cardiovascular disease in the field of in vivo gene editing therapy; gene therapy products, namely, gene transfer, regulation, modulation and delivery pharmaceuticals for the treatment of cardiovascular disease in the field of in vivo gene editing therapy.

Classification kind code

Class [042]
Gene editing, namely, medical and scientific research for the treatment of genetic diseases and disorders in the field of in vivo gene editing therapy; gene editing, namely, pharmaceutical research and development in the field of in vivo gene editing therapy.

Classification kind code

Mark Details

Serial Number

2326649

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 287 on 23^rd May 2024	Pre-Assessment Letter Sent
Submitted for opposition 30 on 10^th May 2024	Filed
Submitted for opposition 1 on 10^th May 2024	Created
Submitted for opposition 31 on 10^th May 2024	Formalized

CTX310

Classification Information

Classification kind code

Class [042]Gene editing, namely, medical and scientific research for the treatment of genetic diseases and disorders in the field of in vivo gene editing therapy; gene editing, namely, pharmaceutical research and development in the field of in vivo gene editing therapy.

Classification kind code

Mark Details

Serial Number

Mark Type

Legal History

Class [042]
Gene editing, namely, medical and scientific research for the treatment of genetic diseases and disorders in the field of in vivo gene editing therapy; gene editing, namely, pharmaceutical research and development in the field of in vivo gene editing therapy.